Södersten, Erik <br/><br/>
Dopamine signaling leads to loss of Polycomb repression and aberrant gene activation in experimental parkinsonism.  [electronic resource] 

 -  PLoS genetics  Sep 2014 
 - e1004574 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1553-7404 
<br/><br/><label>Standard No.: </label>10.1371/journal.pgen.1004574  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Disease Models, Animal<br/>Dopamine--metabolism<br/>Dopamine and cAMP-Regulated Phosphoprotein 32--metabolism<br/>Female<br/>Gene Expression Regulation--drug effects<br/>Genetic Loci<br/>Histones--metabolism<br/>Levodopa--pharmacology<br/>Mice<br/>Mice, Knockout<br/>Parkinsonian Disorders--genetics<br/>Phosphorylation--drug effects<br/>Polycomb-Group Proteins--genetics<br/>Protein Binding<br/>RNA, Messenger--genetics<br/>Ribosomal Protein S6 Kinases, 90-kDa--metabolism<br/>Signal Transduction<br/>Transcriptional Activation